ÌÇÐÄÆƽâ°æ

This statistic is based on a survey conducted in 2016. It describes the personalized medicine program primary focuses of North American and European healthcare organizations in 2016 and 2018. Some 45 percent of respondents stated that the primary focus of their organization's personalized medicine program is diabetes, as of 2016. However, 63 percent expected that this will be the focus in two years time.